Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Bone Biologics (BBLG) Debt Ratio (2016 - 2017)

Bone Biologics (BBLG) has disclosed Debt Ratio for 2 consecutive years, with 12.05 as the latest value for Q3 2017.

  • On a quarterly basis, Debt Ratio fell 37.89% to 12.05 in Q3 2017 year-over-year; TTM through Sep 2017 was 12.05, a 37.89% decrease, with the full-year FY2016 number at 12.5, changed N/A from a year prior.
  • Debt Ratio was 12.05 for Q3 2017 at Bone Biologics, down from 21.98 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 21.98 in Q2 2017 to a low of 3.32 in Q1 2016.